Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
How It Works 
News - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI Summary - About
Nutex Health Inc(NUTX)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Stock price based on last close Advisory Performance History (Simulated)
Upturn Advisory & Investor View for NUTX
11/06/2026: NUTX (3-star) is currently NOT-A-BUY. Pass it for now.
Nutex Health Inc is a healthcare organization that combines a network of community micro-hospitals with a technology-enabled population health platform. The company's main strength lies in this integrated model, which aims to improve both clinical outcomes and operational efficiency. The primary growth opportunity involves scaling its physical hospital footprint while increasing adoption of its Clinigence software among healthcare providers. However, investors should consider significant risks, including high operating costs, intense competition from major hospital systems, and regulatory pressures on reimbursement. The stock may suit growth-oriented investors with high risk tolerance who are looking for exposure to the evolving healthcare services and analytics industry.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Mixed fit | The company offers potential for growth, but remains in a high-risk development phase. |
| Momentum investor | Weak fit | The stock has recently shown downward trends, making it less attractive without a strong positive signal. |
| Value investor | Weak fit | Given current operational volatility and debt levels, the stock does not currently meet traditional value criteria. |
| Dividend investor | Weak fit | The company does not pay dividends and is focused on capital-intensive growth. |
| Low-risk investor | Weak fit | High volatility and operational risks make this unsuitable for conservative portfolios. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | High | The stock is subject to sharp price fluctuations typical of small-cap healthcare entities. |
| Valuation risk | Medium / high | Uncertain future earnings paths make it difficult to determine a stable long-term valuation. |
| Competition risk (Hospital systems) | High | The company faces immense pressure from larger, more established hospital systems with greater economies of scale. |
| Business quality | Medium | While the integrated model is innovative, the operational execution remains in early stages. |
| Dividend income | Low / none | There is no current expectation of income generation for shareholders. |
| Execution risk | High | Successfully managing a network of micro-hospitals requires precise operational control that the company is still proving. |
Price Behavior
Strong Uptrend
The stock has maintained a strong upward price trend across the last three quarters.
Highly Choppy
The stock has experienced frequent, large price swings that make its near-term movement less predictable.
Analysis of Past Performance
Type Stock | Historic Profit 226.91% | Avg. Invested days 27 | Today’s Advisory PASS |
Upturn Advisory Rating  | Upturn Advisory Performance  4.0 | Stock Returns Performance  5.0 |
| Profits based on simulation | Last Close 11/06/2026 |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals
Financial Health Rating
Growth Momentum Score
Ownership
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue)
Economic Dimensions
Quantitative Style Profile
Style Classification
Quality Focused
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 1.24B USD | Price to earnings Ratio 7.81 | 1Y Target Price 296.17 |
Price to earnings Ratio 7.81 | 1Y Target Price 296.17 | ||
Volume (30-day avg) 149.2K shares | Beta 2.01 | 52 Weeks Range 83.99 - 226.16 | Updated Date 11/08/2026 |
52 Weeks Range 83.99 - 226.16 | Updated Date 11/08/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) 23.11 |
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Hospital Facilities | Patient services in emergency rooms and inpatient facilities. | Revenue comes from billing patients and insurers for clinical services provided at their locations. |
| Population Health Services | Software and analytics platform services. | Revenue is generated by licensing data platforms to healthcare providers. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date 2026-11-05 | When After Market | Estimate 5.53 | Actual 5.71 |
Profitability
Profit Margin 20.68% | Operating Margin (TTM) 35.43% |
Management Effectiveness
Return on Assets (TTM) 26.79% | Return on Equity (TTM) 47.61% |
Valuation
Trailing PE 7.81 | Forward PE - | Enterprise Value 1.36B | Price to Sales(TTM) 1.56 |
Enterprise Value 1.36B | Price to Sales(TTM) 1.56 | ||
Enterprise Value to Revenue 1.7 | Enterprise Value to EBITDA 4.07 | Shares Outstanding 6.86M | Shares Floating 4.16M |
Shares Outstanding 6.86M | Shares Floating 4.16M | ||
Percent Insiders 29.23 | Percent Institutions 46.14 |
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.